The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer

被引：0
|
作者：
Jingjia Cao
Xiaolu Zhu
Yaru Sun
Xiao Li
Canhua Yun
Wei Zhang
机构：
[1] the Second Hospital,Department of Nuclear Medicine
[2] Cheeloo College of Medicine,undefined
[3] Shandong University,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2022年 / 49卷
关键词：
BRAF V600E; TERT promoter mutation; Radioiodine therapy; Papillary thyroid carcinoma; Therapy response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3470 / 3481
页数：11
相关论文
共 50 条
  • [31] BRAF V600E Mutations in Infarcted Thyroid Carcinoma
    Kouba, Erik
    Ford, Andrew
    Brown, Charmaine G.
    Yeh, Chen
    Kim, Hyung-Gyoon
    Siegal, Gene P.
    Manne, Upender
    Eltoum, Isam-Eldin
    MODERN PATHOLOGY, 2017, 30 : 327A - 327A
  • [32] Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
    Huang, Meiling
    Yan, Changjiao
    Xiao, Jingjing
    Wang, Ting
    Ling, Rui
    DIAGNOSTIC PATHOLOGY, 2019, 14 (1)
  • [33] Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
    Meiling Huang
    Changjiao Yan
    Jingjing Xiao
    Ting Wang
    Rui Ling
    Diagnostic Pathology, 14
  • [34] Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
    Xing, Mingzhao
    Alzahrani, Ali S.
    Carson, Kathryn A.
    Shong, Young Kee
    Kim, Tae Yong
    Viola, David
    Elisei, Rossella
    Bendlova, Bela
    Yip, Linwah
    Mian, Caterina
    Vianello, Federica
    Tuttle, R. Michael
    Robenshtok, Eyal
    Fagin, James A.
    Puxeddu, Efisio
    Fugazzola, Laura
    Czarniecka, Agnieszka
    Jarzab, Barbara
    O'Neill, Christine J.
    Sywak, Mark S.
    Lam, Alfred K.
    Riesco-Eizaguirre, Garcilaso
    Santisteban, Pilar
    Nakayama, Hirotaka
    Clifton-Bligh, Roderick
    Tallini, Giovanni
    Holt, Elizabeth H.
    Sykorova, Vlasta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) : 42 - U79
  • [35] BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence
    Czarniecka, Agnieszka
    Oczko-Wojciechowska, Malgorzata
    Barczynski, Marcin
    GLAND SURGERY, 2016, 5 (05) : 495 - 505
  • [36] BRAF V600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid Cancer
    Ehlers, Margret
    Schmidt, Mathias
    Mattes-Gyorgy, Katalin
    Antke, Christina
    Enczmann, Juergen
    Schlensog, Martin
    Japp, Anna
    Haase, Matthias
    Allelein, Stephanie
    Dringenberg, Till
    Giesel, Frederik
    Esposito, Irene
    Schott, Matthias
    HORMONE AND METABOLIC RESEARCH, 2022, 54 (12) : 852 - 858
  • [37] Clinical value of BRAF V600E in thyroid carcinoma and the effect of telomerase reverse transcriptase promoter mutations
    Zhao, Chunyan
    Jia, Zhiyun
    Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 2019, 36 (02): : 338 - 342
  • [38] Impact of BRAFV600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer
    Trybek, Tomasz
    Walczyk, Agnieszka
    Gasior-Perczak, Danuta
    Palyga, Iwona
    Mikina, Estera
    Kowalik, Artur
    Hincza, Kinga
    Kopczynski, Janusz
    Chrapek, Magdalena
    Gozdz, Stanislaw
    Kowalska, Aldona
    ENDOCRINOLOGY, 2019, 160 (10) : 2328 - 2338
  • [39] Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
    Rusinek, Dagmara
    Pfeifer, Aleksandra
    Krajewska, Jolanta
    Oczko-Wojciechowska, Malgorzata
    Handkiewicz-Junak, Daria
    Pawlaczek, Agnieszka
    Zebracka-Gala, Jadwiga
    Kowalska, Malgorzata
    Cyplinska, Renata
    Zembala-Nozynska, Ewa
    Chekan, Mykola
    Chmielik, Ewa
    Kropinska, Aleksandra
    Lamch, Roman
    Jurecka-Lubieniecka, Beata
    Jarzab, Barbara
    Czarniecka, Agnieszka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [40] BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas
    da Silva, R. C.
    de Paula, H. S. C.
    Leal, C. B. Q. S.
    Cunha, B. C. R.
    de Paula, E. C.
    Alencar, R. C. G.
    Meneghini, A. J.
    Silva, A. M. T. C.
    Gontijo, A. P.
    Wastowski, I. J.
    Saddi, V. A.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 5065 - 5075
12345